MedTrace Logo

DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections

NCT02185170 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2015-09-22

No results posted yet for this study

Summary

The aim of this study is divided in 4 different steps:

* the first step has two different purpose: assess the impact of the storage medium of fresh prostatic chips on fluorescence signal and adjust the entire chain (immunolabelling,counter-stain and imaging),
* the second step is the adaptation of immunolabelling protocol on histopathology slides, using fresh prostatic tissue,
* the third step is to validate the use of:

1. the medical device created by the FEMTO-ST institute use for the detection of fluorescence signal on fresh tissue,
2. the Light-CT scanner use for tissue structural observation.
* the four step is to check the preservation of morphological structure of tissue under the effect of laser excitation from the medical device.

Conditions

Interventions

PROCEDURE

Trans-urethral resection

All subjects of the study are going to have a trans-urethral resection of prostate.

DEVICE

Use of the FEMTO-ST institute medical device

The FEMTO-ST institute medical device is use to detect prostatic and malignant tissue.

DEVICE

Use of the Light-CT scanner

The Light-CT Scanner is use in the tissue structural observation

Sponsors & Collaborators

  • Laboratoire TIMC-IMAG

    collaborator OTHER

  • FEMTO-ST Institute

    collaborator UNKNOWN

  • LLTech laboratory

    collaborator UNKNOWN

  • Clinical Investigation Center, Technological Innovation (Grenoble and Besancon)

    collaborator UNKNOWN

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Jean-Luc Descotes, MD · University Hospital, Grenoble

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185170 on ClinicalTrials.gov